Everolimus-Eluting Platinum Chromium Coronary Stent System
Outstanding Clinical Outcomes
Excellent Safety and Performance with Promus PtCr EES1
- Over 10,000 Patients Studied
- Over 1 Million Implants
The Promus PREMIERTM Stent is the newest member of the PROMUSTMfamily, featuring the same low dose Everolimus drug and PVDF-HFP polymer combined with the exceptional Platinum Chromium platform. The PLATINUM Clinical Trial Program is the basis for the Promus PREMIER Stent System approval.
Features the only customized Platinum Chromium Stent architecture, the market-leading Everolimus drug and PVDF-HFP polymer combination and an enhanced catheter to provide Premier outcomes.